Recent advances in blood-based biomarkers are transforming the assessment of cognitive decline and Alzheimer’s disease. The Healius Pathology Network offers blood tests that may support clinicians in the investigation of cognitive decline and Alzheimer’s-related amyloid pathology.
Medway Results has been enhanced to help clinicians access and manage pathology information more efficiently.
Subscribe to our monthly newsletter
The Healius Pathology Network incorporating
